Innovation Pharmaceuticals Inc (IPIX)

[williamssc]

My basis is in the reported. Leo reported On December 22nd 2014, Cellceutix also reported positive results in the Microbiological Intent-to-Treat (MITT) population. This is an important population that includes patients with baseline cultures positive for common ABSSSI pathogens, such as Staphylococcus aureus, including Methicillin-Resistant Staphylococcus aureus (MRSA). In this population, Clinical Success rates at 48-72 hours were again very high (above 90% across all treatment groups) and again very similar (with overlapping 95% confidence intervals).

The results sure sound like people being cured of their ABSSSI.

So now as frenchbroad asked, where's is the evidence that the majority experience either hypertensive crises or peripheral neuropathy?